Literature DB >> 28385361

Long-Term Percutaneous Nephrostomy Management of Malignant Urinary Obstruction: Estimation of Optimal Exchange Frequency and Estimation of the Financial Impact of Patient Compliance.

Joseph L McDevitt1, Stefany Acosta-Torres2, Ning Zhang3, Tianshen Hu3, Ayobami Odu3, Jijia Wang3, Yin Xi3, Daniel Lamus3, David S Miller4, Anil K Pillai5.   

Abstract

PURPOSE: To estimate the least costly routine exchange frequency for percutaneous nephrostomies (PCNs) placed for malignant urinary obstruction, as measured by annual hospital charges, and to estimate the financial impact of patient compliance.
MATERIALS AND METHODS: Patients with PCNs placed for malignant urinary obstruction were studied from 2011 to 2013. Exchanges were classified as routine or due to 1 of 3 complication types: mechanical (tube dislodgment), obstruction, or infection. Representative cases were identified, and median representative charges were used as inputs for the model. Accelerated failure time and Markov chain Monte Carlo models were used to estimate distribution of exchange types and annual hospital charges under different routine exchange frequency and compliance scenarios.
RESULTS: Long-term PCN management was required in 57 patients, with 87 total exchange encounters. Median representative hospital charges for pyelonephritis and obstruction were 11.8 and 9.3 times greater, respectively, than a routine exchange. The projected proportion of routine exchanges increased and the projected proportion of infection-related exchanges decreased when moving from a 90-day exchange with 50% compliance to a 60-day exchange with 75% compliance, and this was associated with a projected reduction in annual charges. Projected cost reductions resulting from increased compliance were generally greater than reductions resulting from changes in exchange frequency.
CONCLUSIONS: This simulation model suggests that the optimal routine exchange interval for PCN exchange in patients with malignant urinary obstruction is approximately 60 days and that the degree of reduction in charges likely depends more on patient compliance than exact exchange interval.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28385361     DOI: 10.1016/j.jvir.2017.02.031

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  2 in total

1.  A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.

Authors:  Kouji Izumi; Takashi Shima; Kazuyoshi Shigehara; Kiyoshi Sawada; Renato Naito; Yuki Kato; Mitsuo Ofude; Hiroshi Kano; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazufumi Nakashima; Masashi Iijima; Shohei Kawaguchi; Takahiro Nohara; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

Review 2.  Outcomes Related to Percutaneous Nephrostomies (PCN) in Malignancy-Associated Ureteric Obstruction: A Systematic Review of the Literature.

Authors:  Francesca J New; Sally J Deverill; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.